Home >> About Us >> About Novozymes GroPep

In December 2006 Novozymes GroPep was acquired by the Danish company Novozymes A/S and became Novozymes GroPep Limited.

Novozymes GroPep develops novel factors that increase cell growth, as well as manufactures and commercialises them globally for the pharmaceutical industry:

• As key agents that support the growth of cell types engineered by pharmaceutical companies for the large scale manufacture of new-generation biopharmaceuticals - Cell Culture
• As reagents for researchers to evaluate new medical concepts - Biotechnology Reagents